# OnCo record augment-101 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/augment-101/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "augment-101", "NCT04065399" ;
  schema:name "AUGMENT-101"@en ;
  schema:description "The trial that turned menin inhibition from an idea into the first approved drug for KMT2A-rearranged leukaemia."@en ;
  schema:url <https://onco.cc/trials/augment-101/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04065399> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2019-11-05" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aml-npm1-kmt2a/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:targets <https://onco.cc/targets/menin/>, <https://onco.cc/targets/kmt2a/>, <https://onco.cc/targets/npm1/> ;
  onco:drugs <https://onco.cc/drugs/revumenib/> ;
  onco:companies <https://onco.cc/companies/syndax/> ;
  onco:terms <https://onco.cc/terms/differentiation-syndrome/> ;
  onco:people <https://onco.cc/people/eytan-stein/>, <https://onco.cc/people/ghayas-issa/> .